MSN.com: Startling UK study reveals potential long-term coronavirus complications
January 20, 2021
Dr. Jason Bowling, Infectious Diseases, following his comments to KENS 5 TV about a startling UK study that reveals potential long-term coronavirus complications, had this story propagated by MSN. Read here.
KENS 5: Startling UK study reveals potential long-term coronavirus complications
January 20, 2021
Dr. Jason Bowling, Infectious Diseases, commenting to a KENS 5 TV audience about a startling UK study that reveals potential long-term coronavirus complications, said that a fair number of people experiencing a prolonged ICU stay or hospitalization wil …
Vaccine information for UT Health San Antonio patients and the public
January 20, 2021
Eligible UT Health San Antonio patients will be contacted through MyChart or through phone to schedule their vaccine.
San Antonio Express-News: Your turn: Jan. 18
January 19, 2021
The COVID vaccine staff of UT Health San Antonio received high compliments and grateful appreciation from a reader of the San Antonio Express-News. Paula D. Bondurant, in her letter to the editors, described the vaccine process as efficient, organized, …
Journal article reviews century of data showing COVID-19 likely to impact the brain
January 19, 2021
An article published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association cites decades of published scientific evidence to make a compelling case for SARS-CoV-2’s expected long-term effects on the brain and nervous system.
Yahoo! Finance: Novavax COVID-19 vaccine trial opens at UT Health San Antonio, University Health
January 19, 2021
Dr. Barbara Taylor, Infectious Diseases, was highlighted as the principal investigator of the local study site for the Novavax COVID-19 vaccine trial, part of the COVID-19 Prevention Network, in Yahoo! Finance. Read here.
San Francisco Chronicle: Novavax COVID-19 vaccine trial opens at UT Health San Antonio, University Health
January 19, 2021
Dr. Barbara Taylor, Infectious Diseases, was highlighted as the principal investigator of the local study site for the Novavax COVID-19 vaccine trial, part of the COVID-19 Prevention Network, in the San Francisco Chronicle. Read here.
The Orange Leader: Alzheimer’s insights: Studies research effect of dementia and COVID
January 19, 2021
Dr. Gabriel de Erausquin and Dr. Sudha Seshadri, Neurology/Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and their work on the long-term effects of COVID-19 on the brain, are featured in this column by the Alzheimer’s Associatio …
News 4: Drug combo helps COVID patients recover quicker, doctors say
January 19, 2021
Dr. Thomas Patterson, Infectious Diseases, was interviewed by News 4 San Antonio about the drug combo, that includes baricitinib, which is helping COVID patients recover quicker. Read and watch the story.
NPR: How COVID-19 affects the brain
January 19, 2021
Dr. Gabriel de Erausquin, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, interviewed by NPR Science Correspondent Jon Hamilton, is mentioned in this story about how COVID-19 affects the brain. Listen here.